MG

Manali Ghosh

Active Director Director DIN 10449835
DIN 10449835 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Manali Ghosh

Data last updated:

Manali Ghosh is a Director at Lorfan Pharma Private Limited (since 2024). Lorfan Pharma Private Limited reported revenue of ₹27.1 Lakh (FY 2025).

DIN 10449835
Primary Designation Director
First Appointment 02 Jan 2024
Oldest Company Age 2 yrs
Largest company Lorfan Pharma Private Limited · ₹27.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lorfan Pharma Private Limited U47721WB2024PTC267243
Director02 Jan 20242024₹27.1 Lakh (FY 2025)Active

Board colleagues of Manali Ghosh

Directorship timeline

Open interactive timeline →
Lorfan Pharma Private Limited
Premium access

Shareholding and investment profile for Manali Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manali Ghosh

Manali Ghosh currently holds 1 directorship: Lorfan Pharma Private Limited (Director, since 02 Jan 2024, revenue ₹27.1 Lakh (FY 2025)).

Manali Ghosh was first appointed on 02 Jan 2024 as Director at Lorfan Pharma Private Limited.

The current boards of Manali Ghosh's companies include Rina Nag (Lorfan Pharma Private Limited), Sabari Mondal (Lorfan Pharma Private Limited), Soma Banerjee (Lorfan Pharma Private Limited), Suparna Nag Rajak (Lorfan Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available